We will review the current status of clinical genetic testing and the clinical utility for common prenatal, pediatric, and medical applications. We will emphasize how the field is in flux as new data and knowledge about genomics is emerging. We will review the common clinical situations in which this information is useful and how practitioners and health care systems are commonly using this information. We will discuss the complexity of how the tests are changing, how interpretation of variants is changing, and how clinical management guidelines are changing over time. Because information is complex and still changing, integration of the information into routine health care by non-genetic providers can be challenging and expose providers and health care institutions to liability. We will review the most common liabilities and how to minimize the liability risk by building robust infrastructure and supports within health care systems, integrating genomic information into medical care responsibility and reliably improving medical care and outcomes.
At the conclusion of this learning activity, participants will be able to:
Wendy Chung, MD, PhD, is a medical and molecular geneticist and the Kennedy Family Professor of Pediatrics and Medicine. She received her BA in biochemistry and economics from Cornell University, her MD from Cornell University Medical College, and her PhD from The Rockefeller University in genetics. Dr. Chung directs NIH-funded research programs in human genetics of obesity, breast cancer, pulmonary hypertension, and birth defects including congenital diaphragmatic hernia and congenital heart disease. She leads the Precision Medicine Resource in the Irving Institute at Columbia University.
She has authored over 300 peer reviewed papers and 50 reviews and chapters in medical texts. She was the recipient of the American Academy of Pediatrics Young Investigator Award, the Medical Achievement Award from Bonei Olam, and a career development award from Doris Duke. Dr. Chung is renowned for her teaching and mentoring and received Columbia University’s highest teaching award, the Presidential Award for Outstanding Teaching. She was the original plaintiff in the Supreme Court case that overturned the ability to patent genes and the Institute of Medicine Committee on Genetic Testing.
Dr. Chung enjoys the challenges of genetics as a rapidly changing field of medicine and strives to facilitate the integration of genetic medicine into all areas of health care in a medically, scientifically, and ethically sound, accessible, and cost-effective manner.